Related Experiment Videos
Cognitive function and academic performance in children with neurofibromatosis type 1
1Department of Neurology, Children's Hospital, Camperdown, Sydney, Australia.
Developmental Medicine and Child Neurology
|May 1, 1995
Summary
Neurofibromatosis type 1 (NF1) in children is linked to widespread learning disabilities, not specific deficits. Routine developmental evaluations are crucial for identifying these cognitive challenges in children with NF1.
Area of Science:
- Neuroscience
- Pediatrics
- Genetics
Background:
- Neurofibromatosis type 1 (NF1) is a genetic disorder with varied clinical manifestations.
- Cognitive impairments, including intellectual disability and learning disabilities, are common in NF1.
- The specific profile and prevalence of these learning issues require further elucidation.
Purpose of the Study:
- To determine the frequency of intellectual impairment and learning disabilities in children with NF1.
- To identify the characteristic profile of learning disabilities associated with NF1.
- To investigate the influence of clinical variables on cognitive deficits in NF1.
Main Methods:
- A cohort of 51 children diagnosed with NF1, aged 8–16 years, was evaluated.
- Forty children completed a comprehensive assessment protocol.
- Cognitive functions were assessed to identify intellectual and learning disabilities.
Main Results:
- No specific profile of predominantly visuoperceptual deficits was observed in children with NF1.
- Intellectual quotient (IQ) scores showed no significant discrepancy between verbal and performance measures.
- Cognitive deficits were wide-ranging, and not correlated with clinical factors like age, sex, socioeconomic status, disease severity, macrocephaly, or family history.
Conclusions:
- Learning disabilities in NF1 are not confined to a specific pattern, such as visuoperceptual deficits.
- Cognitive impairments in NF1 are diverse and not predicted by common clinical variables.
- Developmental evaluations should be integrated into the standard care for children with NF1.